This paper was presented at the 2023 American Society of Clinical Oncology (ASCO) held in Chicago Illinois by Drs Lili

This paper was presented at the 2023 American Society of Clinical Oncology (ASCO) held in Chicago Illinois by Drs Amr

This paper was presented at the 2023 American Society of Clinical Oncology (ASCO) held in Chicago Illinois by Drs Catherine

This paper was presented at the 2023 American Society of Clinical Oncology (ASCO) held in Chicago Illinois by Drs Liuwen

This paper was presented at the 2023 American Society of Clinical Oncology (ASCO) held in Chicago Illinois by Drs Liuwen

This paper was presented at the 2023 American Society of Clinical Oncology (ASCO) held in Chicago Illinois by Drs Sheau

This paper was presented at the 2023 American Society of Clinical Oncology (ASCO) held in Chicago Illinois by Drs Erika

This paper was presented at the 2023 American Society of Clinical Oncology (ASCO) held in Chicago Illinois by Drs Ezra

This paper was presented at the 2023 American Society of Clinical Oncology (ASCO) held in Chicago Illinois by Drs Yael

• The randomised phase 3 COMMANDS trial compares the efficacy and tolerability of luspatercept versus epoetin alfa in patients with